Anika Therapeutics - 27 Year Stock Price History | ANIK

Historical daily share price chart and data for Anika Therapeutics since 1993 adjusted for splits. The latest closing stock price for Anika Therapeutics as of November 27, 2020 is 38.27.
  • The all-time high Anika Therapeutics stock closing price was 73.36 on October 25, 2019.
  • The Anika Therapeutics 52-week high stock price is 58.73, which is 53.5% above the current share price.
  • The Anika Therapeutics 52-week low stock price is 22.01, which is 42.5% below the current share price.
  • The average Anika Therapeutics stock price for the last 52 weeks is 37.97.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Anika Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 36.4841 52.4000 54.0600 22.3800 38.2700 -26.19%
2019 45.1985 34.5200 73.3600 29.3700 51.8500 54.27%
2018 43.2097 54.9100 68.4300 28.7700 33.6100 -37.66%
2017 50.3632 50.1100 59.9400 41.7200 53.9100 10.11%
2016 45.8884 38.0800 54.2600 35.3000 48.9600 28.30%
2015 37.2732 39.7600 45.2100 31.3500 38.1600 -6.33%
2014 41.0168 34.9900 50.4300 29.4800 40.7400 6.76%
2013 20.0087 10.8700 38.1600 10.2200 38.1600 283.90%
2012 12.7090 9.3100 17.5400 9.0800 9.9400 1.43%
2011 7.5280 6.7300 11.1700 5.3300 9.8000 46.93%
2010 6.2777 7.5600 7.9000 4.9500 6.6700 -12.58%
2009 5.6700 3.1200 9.0500 3.0500 7.6300 150.99%
2008 8.3621 15.1800 15.1800 3.0000 3.0400 -79.11%
2007 15.4437 13.1700 21.8000 12.3100 14.5500 9.65%
2006 11.9701 11.5400 14.7400 9.5000 13.2700 13.52%
2005 12.1348 9.0000 17.0000 8.1000 11.6900 27.76%
2004 11.4183 9.3600 17.5300 6.8000 9.1500 -6.06%
2003 4.1682 1.0400 11.5000 0.9900 9.7400 883.84%
2002 1.1214 1.1000 1.3900 0.8500 0.9900 -1.00%
2001 1.1379 0.8125 1.6880 0.8125 1.0000 27.99%
2000 4.2242 7.0000 11.5000 0.7500 0.7813 -88.94%
1999 5.9460 5.0630 8.6880 4.5000 7.0630 31.40%
1998 10.2554 8.6250 18.1900 3.9380 5.3750 -42.28%
1997 6.7512 3.8750 10.5000 3.8750 9.3130 148.35%
1996 4.7312 3.8800 7.5000 3.4400 3.7500 -3.23%
1995 2.5569 1.8750 3.8750 1.6200 3.8750 106.67%
1994 2.7154 4.0310 4.1250 1.5000 1.8750 -58.04%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.544B $0.115B
Anika Therapeutics, Inc. is a global, integrated orthopedic medicines company based in Bedford, Massachusetts. Anika is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies along the continuum of care, from palliative pain management to regenerative cartilage repair. Anika's orthopedic medicine portfolio includes ORTHOVISC, MONOVISC, and CINGAL, which alleviate pain and restore joint function by replenishing depleted HA, and HYALOFAST, a solid HA-based scaffold to aid cartilage repair and regeneration.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $142.187B 10.14
Amgen (AMGN) United States $128.258B 13.41
CSL (CSLLY) Australia $104.516B 0.00
Gilead Sciences (GILD) United States $74.585B 9.92
Vertex Pharmaceuticals (VRTX) United States $56.714B 26.37
Regeneron Pharmaceuticals (REGN) United States $54.240B 19.24
Illumina (ILMN) United States $44.381B 61.04
Moderna (MRNA) United States $43.204B 0.00
Biogen (BIIB) United States $37.201B 6.61
Seagen (SGEN) United States $29.832B 78.79
Alexion Pharmaceuticals (ALXN) United States $26.903B 10.72
BeiGene (BGNE) Cayman Islands $23.985B 0.00
BioNTech SE (BNTX) Germany $23.748B 0.00
Genmab (GMAB) Denmark $23.537B 27.84
Genmab (GNMSF) Denmark $22.400B 5.16
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.638B 0.00
Incyte (INCY) United States $17.774B 0.00
Exact Sciences (EXAS) United States $17.430B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.674B 59.44
Horizon Therapeutics Public (HZNP) Ireland $15.207B 21.74
Alnylam Pharmaceuticals (ALNY) United States $14.575B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.187B 94.16
ARGENX SE-ADR (ARGX) Netherlands $12.480B 0.00
Bio-Techne Corp (TECH) United States $11.650B 74.51
Mirati Therapeutics (MRTX) United States $11.336B 0.00
Guardant Health (GH) United States $11.261B 0.00
QIAGEN (QGEN) Netherlands $10.761B 24.23
Sarepta Therapeutics (SRPT) United States $10.710B 0.00
Repligen (RGEN) United States $9.547B 135.40
ACADIA Pharmaceuticals (ACAD) United States $8.881B 0.00
Ascendis Pharma (ASND) Denmark $8.661B 0.00
Galapagos (GLPG) Belgium $7.892B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $7.772B 0.00
Ultragenyx Pharmaceutical (RARE) United States $7.315B 0.00
Denali Therapeutics (DNLI) United States $7.269B 0.00
Acceleron Pharma (XLRN) United States $6.854B 0.00
Novavax (NVAX) United States $6.532B 0.00
Adaptive Biotechnologies (ADPT) United States $6.268B 0.00
Amicus Therapeutics (FOLD) United States $5.931B 0.00
Blueprint Medicines (BPMC) United States $5.870B 19.43
Exelixis (EXEL) United States $5.811B 39.02
Halozyme Therapeutics (HALO) United States $5.561B 257.13
SWEDISH ORP BIO (BIOVF) Sweden $5.208B 14.23
Reata Pharmaceuticals (RETA) United States $5.146B 0.00
NeoGenomics (NEO) United States $5.075B 1523.67
Fate Therapeutics (FATE) United States $4.984B 0.00
China Biologic Products (CBPO) China $4.674B 30.29
Twist Bioscience (TWST) United States $4.450B 0.00
Emergent Biosolutions (EBS) United States $4.262B 13.98
Insmed (INSM) United States $3.930B 0.00
Arena Pharmaceuticals (ARNA) United States $3.810B 0.00
Legend Biotech (LEGN) United States $3.760B 0.00
Vir Biotechnology (VIR) United States $3.619B 0.00
MorphoSys AG (MOR) Germany $3.532B 127.86
Deciphera Pharmaceuticals (DCPH) United States $3.518B 0.00
Eidos Therapeutics (EIDX) United States $3.430B 0.00
Alkermes (ALKS) Ireland $2.933B 28.80
Bluebird Bio (BLUE) United States $2.869B 0.00
Global Blood Therapeutics (GBT) United States $2.710B 0.00
Seres Therapeutics (MCRB) United States $2.682B 0.00
Beam Therapeutics (BEAM) United States $2.591B 0.00
Zymeworks (ZYME) Canada $2.225B 0.00
Intellia Therapeutics (NTLA) United States $2.119B 0.00
I-Mab (IMAB) China $2.111B 0.00
Viela Bio (VIE) United States $2.073B 0.00
UniQure (QURE) Netherlands $2.069B 0.00
Intra-Cellular Therapies (ITCI) United States $2.051B 0.00
PHARMA MAR SA (PHMMF) Spain $1.921B 0.00
Editas Medicine (EDIT) United States $1.836B 0.00
Sorrento Therapeutics (SRNE) United States $1.814B 0.00
Amarin (AMRN) Ireland $1.799B 0.00
Mesoblast (MESO) Australia $1.793B 0.00
Inovio Pharmaceuticals (INO) United States $1.760B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.754B 0.00
Mersana Therapeutics (MRSN) United States $1.705B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.674B 0.00
Revance Therapeutics (RVNC) United States $1.631B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.607B 13.30
Arcus Biosciences (RCUS) United States $1.582B 0.00
NGM Biopharmaceuticals (NGM) United States $1.572B 0.00
Scholar Rock Holding (SRRK) United States $1.504B 0.00
Alcobra (ARCT) United States $1.485B 0.00
Zealand Pharma (ZEAL) Denmark $1.444B 0.00
Ligand Pharmaceuticals (LGND) United States $1.406B 36.42
Precigen (PGEN) United States $1.387B 0.00
Sangamo Therapeutics (SGMO) United States $1.382B 0.00
Myriad Genetics (MYGN) United States $1.370B 0.00
Adverum Biotechnologies (ADVM) United States $1.346B 0.00
REGENXBIO (RGNX) United States $1.334B 0.00
Coherus BioSciences (CHRS) United States $1.300B 8.60
Zealand Pharma (ZLDPF) Denmark $1.287B 0.00
Athenex (ATNX) United States $1.279B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.234B 0.00
Epizyme (EPZM) United States $1.204B 0.00
Heska (HSKA) United States $1.195B 0.00
Cytokineticsorporated (CYTK) United States $1.174B 0.00
Genetron Holdings (GTH) China $1.173B 0.00
Travere Therapeutics (TVTX) United States $1.164B 0.00
Vericel (VCEL) United States $1.134B 0.00
Codexis (CDXS) United States $1.059B 0.00
Pliant Therapeutics (PLRX) United States $1.056B 0.00
Alector (ALEC) United States $1.053B 0.00
Morphic Holding (MORF) United States $1.014B 0.00
Northwest Biotherapeutics (NWBO) United States $1.014B 0.00
Cellectis S.A (CLLS) France $0.953B 0.00
Arvinas (ARVN) United States $0.950B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.945B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.900B 0.00
Protagonist Therapeutics (PTGX) United States $0.885B 0.00
Frequency Therapeutics (FREQ) United States $0.879B 0.00
Castle Biosciences (CSTL) United States $0.868B 0.00
Celldex Therapeutics (CLDX) United States $0.861B 0.00
Compugen (CGEN) Israel $0.844B 0.00
NantKwest (NK) United States $0.819B 0.00
Pharming Group (PHGUF) Netherlands $0.753B 17.19
Cardiff Oncology (CRDF) United States $0.753B 0.00
Cara Therapeutics (CARA) United States $0.750B 0.00
MiMedx (MDXG) United States $0.726B 0.00
Albireo Pharma (ALBO) United States $0.705B 0.00
Five Prime Therapeutics (FPRX) United States $0.702B 0.00
Kadmon Holdings (KDMN) United States $0.696B 0.00
MannKind (MNKD) United States $0.686B 0.00
AnaptysBio (ANAB) United States $0.675B 0.00
Agenus (AGEN) United States $0.667B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.662B 33.64
VBI Vaccines (VBIV) United States $0.658B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Sutro Biopharma (STRO) United States $0.637B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.635B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.626B 0.00
Precision BioSciences (DTIL) United States $0.604B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.600B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.598B 0.00
IVERIC Bio (ISEE) United States $0.564B 0.00
Geron (GERN) United States $0.562B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.534B 0.00
MeiraGTx Holdings (MGTX) United States $0.527B 0.00
Avid Bioservices (CDMO) United States $0.497B 0.00
Forte Biosciences (FBRX) United States $0.490B 0.00
Cel-Sci (CVM) United States $0.482B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.476B 0.00
Merus (MRUS) Netherlands $0.471B 0.00
Dynavax Technologies (DVAX) United States $0.468B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.466B 0.00
WAVE Life Sciences (WVE) Singapore $0.449B 0.00
Prothena (PRTA) Ireland $0.446B 0.00
Puma Biotechnology (PBYI) United States $0.439B 0.00
Spero Therapeutics (SPRO) United States $0.433B 0.00
Amryt Pharma (AMYT) United Kingdom $0.430B 0.00
UROGEN PHARMA (URGN) United States $0.426B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.417B 0.00
Kala Pharmaceuticals (KALA) United States $0.409B 0.00
Innate Pharma S.A (IPHA) France $0.409B 0.00
Starpharma Holdings (SPHRY) Australia $0.401B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.397B 0.00
Affimed (AFMD) Germany $0.395B 0.00
Clovis Oncology (CLVS) United States $0.392B 0.00
Cue Biopharma (CUE) United States $0.385B 0.00
BioDelivery Sciences (BDSI) United States $0.376B 17.71
AC Immune SA (ACIU) Switzerland $0.373B 0.00
Trevena (TRVN) United States $0.367B 0.00
Syros Pharmaceuticals (SYRS) United States $0.363B 0.00
Cellular Biomedicine (CBMG) United States $0.363B 0.00
ANI Pharmaceuticals (ANIP) United States $0.362B 9.20
XOMA (XOMA) United States $0.360B 0.00
Selecta Biosciences (SELB) United States $0.353B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.350B 0.00
Athersys (ATHX) United States $0.350B 0.00
CytomX Therapeutics (CTMX) United States $0.340B 0.00
Arbutus Biopharma (ABUS) United States $0.320B 0.00
ChromaDex (CDXC) United States $0.300B 0.00
Kamada (KMDA) Israel $0.295B 13.79
CorMedix Inc (CRMD) United States $0.294B 0.00
PDL BioPharma (PDLI) United States $0.292B 0.00
Verastem (VSTM) United States $0.289B 0.00
NextCure (NXTC) United States $0.281B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.278B 0.00
IBio (IBIO) United States $0.266B 0.00
DBV Technologies S.A (DBVT) France $0.260B 0.00
Fortress Biotech (FBIO) United States $0.245B 0.00
HOOKIPA Pharma (HOOK) United States $0.243B 0.00
TELA Bio (TELA) United States $0.241B 0.00
Pluristem Therapeutics (PSTI) Israel $0.239B 0.00
Aptinyx (APTX) United States $0.216B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.198B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.194B 0.00
AquaBounty Technologies (AQB) United States $0.187B 0.00
GENFIT S.A (GNFT) France $0.186B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
Theratechnologies (THTX) Canada $0.182B 0.00
Eton Pharmaceuticals (ETON) United States $0.182B 0.00
Aptevo Therapeutics (APVO) United States $0.182B 0.00
Cerecor (CERC) United States $0.181B 0.00
Strongbridge Biopharma (SBBP) United States $0.180B 0.00
Bellus Health (BLU) Canada $0.178B 0.00
ADMA Biologics Inc (ADMA) United States $0.173B 0.00
Nicox SA (NICXF) France $0.170B 0.00
Checkpoint Therapeutics (CKPT) United States $0.164B 0.00
Biofrontera AG (BFRA) Germany $0.162B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.162B 0.00
VolitionRX (VNRX) United States $0.161B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.159B 0.00
Kindred Biosciences (KIN) United States $0.158B 0.00
Dyadic (DYAI) United States $0.156B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.155B 0.00
Oncobiologics (OTLK) United States $0.154B 0.00
SESEN BIO, INC (SESN) United States $0.149B 0.00
VTv Therapeutics (VTVT) United States $0.148B 0.00
Idera Pharmaceuticals (IDRA) United States $0.141B 0.00
Abeona Therapeutics (ABEO) United States $0.139B 0.00
Celyad SA (CYAD) Belgium $0.134B 0.00
Lumos Pharma (LUMO) United States $0.131B 0.00
Protalix BioTherapeutics (PLX) Israel $0.128B 0.00
Catalyst Biosciences (CBIO) United States $0.128B 0.00
Gritstone Oncology (GRTS) United States $0.128B 0.00
TRACON Pharmaceuticals (TCON) United States $0.125B 0.00
Exicure (XCUR) United States $0.123B 0.00
Antibe Therapeutics (ATBPF) Canada $0.120B 0.00
Orgenesis (ORGS) United States $0.117B 243.00
Cocrystal Pharma (COCP) United States $0.117B 0.00
Aytu Bioscience (AYTU) United States $0.115B 0.00
Applied Genetic Technologies (AGTC) United States $0.111B 0.00
Liquidia Technologies (LQDA) United States $0.111B 0.00
Cyclerion Therapeutics (CYCN) United States $0.110B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.108B 0.00
Cogent Biosciences (COGT) United States $0.108B 0.00
Windtree Therapeutics (WINT) United States $0.107B 0.00
DiaMedica Therapeutics (DMAC) United States $0.105B 0.00
Palatin Technologies (PTN) United States $0.102B 0.00
Cidara Therapeutics (CDTX) United States $0.101B 0.00
Clearside Biomedical (CLSD) United States $0.095B 0.00
Enzo Biochem (ENZ) United States $0.094B 0.00
Prometic Life Sciences (LMNL) Canada $0.094B 0.00
Novogen (KZIA) Australia $0.093B 0.00
ARAVIVE, INC (ARAV) United States $0.093B 0.00
AIT Therapeutics (XAIR) United States $0.092B 0.00
Ecology Coatings (ABVC) United States $0.086B 0.00
Synlogic (SYBX) United States $0.085B 0.00
Curis (CRIS) United States $0.081B 0.00
AnPac Bio-Medical Science (ANPC) China $0.080B 0.00
Bionano Genomics (BNGO) United States $0.075B 0.00
Evogene (EVGN) Israel $0.075B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.073B 0.00
Prima BioMed (IMMP) Australia $0.073B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.071B 0.00
Stealth BioTherapeutics (MITO) United States $0.069B 33.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.068B 0.00
Adocia (ADOCY) France $0.067B 0.00
MiRagen Therapeutics (MGEN) United States $0.063B 0.00
Soligenix (SNGX) United States $0.061B 0.00
Emmaus Life Sciences (EMMA) United States $0.061B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.060B 0.00
Armata Pharmaceuticals (ARMP) United States $0.059B 0.00
Organovo Holdings (ONVO) United States $0.058B 0.00
Proteostasis Therapeutics (PTI) United States $0.055B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.054B 0.00
Appili Therapeutics (APLIF) Canada $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Happiness Biotech Group (HAPP) China $0.050B 0.00
Edesa Biotech (EDSA) Canada $0.050B 0.00
Seelos Therapeutics (SEEL) United States $0.048B 0.00
Vaccinex (VCNX) United States $0.046B 0.00
CollPlant Holdings (CLGN) Israel $0.045B 0.00
Pulmatrix (PULM) United States $0.044B 0.00
Genetic Technologies (GENE) Australia $0.042B 0.00
IMMURON (IMRN) Australia $0.042B 0.00
Cleveland BioLabs (CBLI) United States $0.041B 0.00
Titan Pharmaceuticals (TTNP) United States $0.037B 0.00
ATyr Pharma (LIFE) United States $0.037B 0.00
Chanticleer Holdings (SONN) United States $0.035B 0.00
Acorda Therapeutics (ACOR) United States $0.034B 0.00
OvaScience (MLND) United States $0.033B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.030B 0.00
BioCardia (BCDA) United States $0.029B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.026B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.025B 0.00
AEterna Zentaris (AEZS) United States $0.025B 0.00
Alimera Sciences (ALIM) United States $0.024B 0.00
Prana Biotechnology (ATHE) Australia $0.023B 0.00
Celsion (CLSN) United States $0.020B 0.00
Cesca Therapeutics (THMO) United States $0.019B 0.00
Advaxis (ADXS) United States $0.019B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.018B 0.00
Spherix (AIKI) United States $0.018B 0.00
Invo BioScience (INVO) United States $0.016B 0.00
MedAvail Holdings (MDVL) United States $0.015B 0.00
BioPharmX (TMBR) United States $0.014B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
GeoVax Labs (GOVX) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00